Department of Medicine, Hebei Key Laboratory of Gastroenterology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
Liver Int. 2012 Jul;32(6):1018-26. doi: 10.1111/j.1478-3231.2012.02821.x.
BACKGROUND/AIM: TNF-α is increased in hepatopulmonary syndrome (HPS). Pentoxifylline (PTX) mitigated experimental HPS through the inhibition of TNF-α. However, PTX has pleiotropic effects besides the inhibition of TNF-α. This study is to neutralize TNF-α with specific monoclonal antibody to TNF-α (TNF-α McAb) to investigate the effect of TNF-α on HPS.
Hepatopulmonary syndrome was induced by common bile duct ligation (CBDL); controls were sham operated. The endpoints were 1, 2, 3, 4 and 5 weeks after surgery. (99m) Technetium-macroaggregated albumin (Tc-MAA) was to evaluate intrapulmonary arteriovenous shunts; Portal venous pressure, cardiac output and mean blood pressure (MAP) were also measured. Serum was for Alanine transaminase (ALT), endotoxin, TNF-α and nitric oxide (NO) measurements, liver for histology, lung for histology and iNOS, PI3K/Akt expression assay.
Portal vein pressure was significantly elevated and MAP decreased in CBDL rats. Tc-MAA was mainly located in lung and very weak in brain in sham group and mainly in brain of CBDL rats. TNF-α McAb significantly decreased the radioactivity in the brain, reduced cardiac output, increased MAP and systemic vascular resistance (SVR) in CBDL animals. Serum ALT, endotoxin, TNF-α and NO were significantly increased. TNF-α McAb significantly decreased these serum indices in CBDL rats. TNF-α McAb significantly alleviated liver damage, decreased alveolar-arterial gradient and inhibited iNOS, PI3K/Akt and p-Akt expression in lung tissue. Furthermore, TNF-α McAb significantly attenuated the inflammatory response in lung.
TNF-α McAb improves HPS in cirrhotic rats; this effect is likely mediated through the inhibition of TNF-α PI3K/Akt-NO pathway.
背景/目的:肿瘤坏死因子-α(TNF-α)在肝肺综合征(HPS)中增加。己酮可可碱(PTX)通过抑制 TNF-α减轻了实验性 HPS。然而,PTX 除了抑制 TNF-α之外,还具有多种作用。本研究使用 TNF-α 特异性单克隆抗体(TNF-α McAb)中和 TNF-α,以研究 TNF-α 对 HPS 的影响。
通过胆总管结扎(CBDL)诱导 HPS;对照组进行假手术。术后 1、2、3、4 和 5 周为终点。(99m)锝-聚合白蛋白(Tc-MAA)用于评估肺内动静脉分流;门静脉压、心输出量和平均血压(MAP)也进行了测量。血清用于丙氨酸转氨酶(ALT)、内毒素、TNF-α 和一氧化氮(NO)的测量,肝脏用于组织学检查,肺用于组织学和 iNOS、PI3K/Akt 表达测定。
CBDL 大鼠门静脉压明显升高,MAP 降低。Tc-MAA 在假手术组主要位于肺,在脑内很少,而在 CBDL 大鼠主要位于脑内。TNF-α McAb 显著降低了 CBDL 动物脑内的放射性,降低了心输出量,增加了 MAP 和全身血管阻力(SVR)。血清 ALT、内毒素、TNF-α 和 NO 明显升高。TNF-α McAb 显著降低了 CBDL 大鼠的这些血清指标。TNF-α McAb 显著减轻了肝损伤,降低了肺泡-动脉梯度,并抑制了肺组织中 iNOS、PI3K/Akt 和 p-Akt 的表达。此外,TNF-α McAb 显著减轻了肺组织中的炎症反应。
TNF-α McAb 改善了肝硬化大鼠的 HPS;这种作用可能是通过抑制 TNF-α-PI3K/Akt-NO 途径介导的。